10 Best Cannatech for February 2026
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Market Overview & Selection Criteria
The cannatech sector, encompassing cannabis technology and related consumer goods, presents a mix of established players and high-growth challengers amid evolving regulatory landscapes and shifting consumer trends. These 10 best cannatech stock picks were selected using ValueSense's proprietary intrinsic value tools, focusing on companies showing potential undervaluation based on DCF models, quality ratings above 4.0, and key metrics like ROIC, FCF margins, and revenue growth. Methodology emphasizes undervalued stocks to buy in this niche, prioritizing those with strong gross margins and intrinsic value upside, drawn exclusively from ValueSense data for educational analysis. This watchlist balances tobacco giants with pure-play cannabis innovators, ideal for cannabis stock picks research.
Featured Stock Analysis
Stock #1: Altria Group, Inc. (MO)
| Metric | Value |
|---|---|
| Market Cap | $112.2B |
| Quality Rating | 7.2 |
| Intrinsic Value | $101.3 |
| 1Y Return | 25.6% |
| Revenue | $20.9B |
| Free Cash Flow | $11.5B |
| Revenue Growth | 2.3% |
| FCF margin | 54.8% |
| Gross margin | 69.6% |
| ROIC | 75.4% |
| Total Debt to Equity | (1,444.1%) |
Investment Thesis
Altria Group, Inc. (MO) stands out with a robust market cap of $112.2B and a high Quality rating of 7.2, signaling strong operational efficiency in the consumer staples space with tobacco exposure relevant to cannatech transitions. Its intrinsic value of $101.3 suggests significant undervaluation potential, supported by impressive revenue of $20.9B, Free Cash Flow of $11.5B, and an exceptional FCF margin of 54.8%. The Gross margin at 69.6% and ROIC of 75.4% highlight superior capital allocation, despite modest revenue growth of 2.3% and a 1Y Return of 25.6%. This positions MO as a stable anchor for cannatech portfolios seeking reliable cash flows amid sector volatility.
High Total Debt to Equity at 1,444.1% reflects leverage typical in mature tobacco firms pivoting toward alternatives, but towering profitability metrics underscore resilience for value-oriented analysis.
Key Catalysts
- Exceptional ROIC of 75.4% driving efficient reinvestment.
- Massive FCF of $11.5B enabling dividends and buybacks.
- Strong gross margin of 69.6% supporting pricing power.
Risk Factors
- Elevated Total Debt to Equity 1,444.1% amplifying interest rate sensitivity.
- Slow revenue growth of 2.3% in maturing tobacco markets.
- Regulatory pressures on nicotine products impacting transitions.
Stock #2: Constellation Brands, Inc. (STZ)
| Metric | Value |
|---|---|
| Market Cap | $28.7B |
| Quality Rating | 6.1 |
| Intrinsic Value | $62.2 |
| 1Y Return | 0.8% |
| Revenue | $9,382.5M |
| Free Cash Flow | $432.4M |
| Revenue Growth | (7.9%) |
| FCF margin | 4.6% |
| Gross margin | 52.0% |
| ROIC | 19.6% |
| Total Debt to Equity | 133.3% |
Investment Thesis
Constellation Brands, Inc. (STZ), with a $28.7B market cap and Quality rating of 6.1, offers exposure to beverage innovation intersecting cannatech via cannabis-infused products potential. Intrinsic value at $62.2 indicates undervaluation, backed by revenue of $9,382.5M and FCF of $432.4M, though revenue growth is -7.9% and 1Y Return at 0.8%. Solid gross margin of 52.0%, FCF margin of 4.6%, and ROIC of 19.6% demonstrate quality operations, with Total Debt to Equity at 133.3% manageable for a scaled player.
This analysis reveals STZ's defensive positioning in consumer goods, with metrics suggesting recovery potential in a stock watchlist for diversified cannatech plays.
Key Catalysts
- Healthy ROIC of 19.6% for operational leverage.
- Strong gross margin of 52.0% amid premium branding.
- FCF positivity at $432.4M supporting expansion.
Risk Factors
- Negative revenue growth of 7.9% signaling demand softness.
- Moderate FCF margin of 4.6% vulnerable to cost pressures.
- Debt to Equity of 133.3% in rising rate environments.
Stock #3: Chart Industries, Inc. (GTLS)
| Metric | Value |
|---|---|
| Market Cap | $9,306.6M |
| Quality Rating | 5.9 |
| Intrinsic Value | $194.4 |
| 1Y Return | 7.3% |
| Revenue | $4,291.2M |
| Free Cash Flow | $397.5M |
| Revenue Growth | (9.0%) |
| FCF margin | 9.3% |
| Gross margin | 33.8% |
| ROIC | 5.7% |
| Total Debt to Equity | 108.3% |
Investment Thesis
Chart Industries, Inc. (GTLS) features a $9,306.6M market cap and Quality rating of 5.9, linking industrial tech to cannatech through cryogenic solutions for processing. Intrinsic value of $194.4 points to deep undervaluation, with revenue of $4,291.2M, FCF of $397.5M, and 1Y Return of 7.3%. Despite revenue growth of -9.0%, FCF margin of 9.3%, gross margin of 33.8%, and ROIC of 5.7% indicate improving fundamentals, balanced by Total Debt to Equity of 108.3%.
GTLS analysis highlights infrastructure plays in emerging cannatech supply chains, offering growth levers for investment opportunities.
Key Catalysts
- Attractive intrinsic value upside to $194.4.
- Positive FCF of $397.5M for tech investments.
- ROIC of 5.7% trending toward efficiency.
Risk Factors
- Declining revenue growth of 9.0% from cyclical pressures.
- Debt levels at 108.3% of equity.
- Lower gross margin of 33.8% vs. peers.
Stock #4: Cronos Group Inc. (CRON)
| Metric | Value |
|---|---|
| Market Cap | $996.0M |
| Quality Rating | 5.7 |
| Intrinsic Value | $2.2 |
| 1Y Return | 29.8% |
| Revenue | $166.5M |
| Free Cash Flow | ($5,673.2K) |
| Revenue Growth | 49.0% |
| FCF margin | (3.4%) |
| Gross margin | 34.5% |
| ROIC | (7.5%) |
| Total Debt to Equity | 0.2% |
Investment Thesis
Cronos Group Inc. (CRON), at $996.0M market cap with Quality rating 5.7, is a pure-play cannatech firm showing revenue growth of 49.0% and 1Y Return of 29.8%. Intrinsic value $2.2 suggests caution, with revenue $166.5M, negative FCF of $5,673.2K, FCF margin -3.4%, gross margin 34.5%, ROIC -7.5%, and low Total Debt to Equity 0.2%. This profile suits high-risk, high-reward cannabis stock picks analysis.
Strong growth metrics offset cash burn, positioning CRON for regulatory tailwinds in educational watchlists.
Key Catalysts
- Robust revenue growth of 49.0% in expansion.
- Clean debt to equity of 0.2%.
- Solid gross margin of 34.5%.
Risk Factors
- Negative FCF and ROIC indicating burn.
- Low intrinsic value $2.2 vs. peers.
- Small-cap volatility.
Most investors waste time on the wrong metrics. We've spent 10,000+ hours perfecting our value investing engine to find what actually matters.
Want to see what we'll uncover next - before everyone else does?
Find Hidden Gems First!
Stock #5: Tilray Brands, Inc. (TLRY)
| Metric | Value |
|---|---|
| Market Cap | $833.1M |
| Quality Rating | 6.1 |
| Intrinsic Value | $23.1 |
| 1Y Return | 689.0% |
| Revenue | $1,003.5M |
| Free Cash Flow | ($49.2M) |
| Revenue Growth | 21.0% |
| FCF margin | (4.9%) |
| Gross margin | 28.2% |
| ROIC | (493.2%) |
| Total Debt to Equity | N/A |
Investment Thesis
Tilray Brands, Inc. (TLRY) boasts $833.1M market cap, Quality rating 6.1, explosive 1Y Return of 689.0%, and revenue growth 21.0% on $1,003.5M revenue. Intrinsic value $23.1 implies upside, despite FCF -$49.2M, FCF margin -4.9%, gross margin 28.2%, extreme ROIC -493.2%, and N/A debt. TLRY exemplifies volatile cannatech growth for undervalued stocks scrutiny.
Key Catalysts
- Stellar 1Y Return 689.0% momentum.
- Revenue growth 21.0% scaling operations.
- High intrinsic value potential.
Risk Factors
- Severe ROIC -493.2% and FCF losses.
- Ongoing cash burn.
- Regulatory uncertainties.
Stock #6: Cannae Holdings, Inc. (CNNE)
| Metric | Value |
|---|---|
| Market Cap | $735.2M |
| Quality Rating | 4.4 |
| Intrinsic Value | $23.4 |
| 1Y Return | -31.2% |
| Revenue | $430.2M |
| Free Cash Flow | ($46.6M) |
| Revenue Growth | (6.9%) |
| FCF margin | (10.8%) |
| Gross margin | 8.3% |
| ROIC | (156.4%) |
| Total Debt to Equity | 17.8% |
Investment Thesis
Cannae Holdings, Inc. (CNNE) has $735.2M market cap, Quality rating 4.4, intrinsic value $23.4, but 1Y Return -31.2% and revenue growth -6.9% on $430.2M revenue. FCF -$46.6M, FCF margin -10.8%, low gross margin 8.3%, ROIC -156.4%, and debt 17.8% flag challenges in cannatech holding analysis.
Key Catalysts
- Intrinsic value $23.4 upside.
- Manageable debt 17.8%.
- Diversified holdings potential.
Risk Factors
- Negative 1Y Return and growth.
- Poor margins and ROIC.
- Persistent losses.
Stock #7: SNDL Inc. (SNDL)
| Metric | Value |
|---|---|
| Market Cap | $378.3M |
| Quality Rating | 5.2 |
| Intrinsic Value | $5.1 |
| 1Y Return | -17.6% |
| Revenue | CA$951.6M |
| Free Cash Flow | CA$57.6M |
| Revenue Growth | 4.4% |
| FCF margin | 6.1% |
| Gross margin | 27.0% |
| ROIC | (14.7%) |
| Total Debt to Equity | 14.1% |
Investment Thesis
SNDL Inc. (SNDL) shows $378.3M market cap, Quality rating 5.2, intrinsic value $5.1, revenue CA$951.6M with growth 4.4%, positive FCF CA$57.6M (margin 6.1%), gross margin 27.0%, ROIC -14.7%, debt 14.1%, and 1Y Return -17.6%. Positive FCF distinguishes it in cannatech.
Key Catalysts
- Positive FCF CA$57.6M.
- Steady revenue growth 4.4%.
- Low debt 14.1%.
Risk Factors
- Negative ROIC and 1Y Return.
- Canadian currency exposure.
- Competitive pressures.
Stock #8: Canopy Growth Corporation (CGC)
| Metric | Value |
|---|---|
| Market Cap | $357.6M |
| Quality Rating | 4.2 |
| Intrinsic Value | $2.6 |
| 1Y Return | -42.5% |
| Revenue | $309.2M |
| Free Cash Flow | ($85.7M) |
| Revenue Growth | 7.3% |
| FCF margin | (27.7%) |
| Gross margin | 19.7% |
| ROIC | (10.9%) |
| Total Debt to Equity | 35.9% |
Investment Thesis
Canopy Growth Corporation (CGC) at $357.6M market cap, Quality rating 4.2, intrinsic value $2.6, revenue $309.2M (growth 7.3%), but FCF -$85.7M (margin -27.7%), gross margin 19.7%, ROIC -10.9%, debt 35.9%, 1Y Return -42.5%. Growth amid losses for analysis.
Key Catalysts
- Improving revenue growth 7.3%.
- Established brand.
- Potential M&A.
Risk Factors
- Heavy FCF losses.
- Low intrinsic value.
- High 1Y decline.
Stock #9: High Tide Inc. (HITI)
| Metric | Value |
|---|---|
| Market Cap | $199.9M |
| Quality Rating | 5.6 |
| Intrinsic Value | $1.4 |
| 1Y Return | -12.2% |
| Revenue | CA$594.0M |
| Free Cash Flow | CA$13.3M |
| Revenue Growth | 13.7% |
| FCF margin | 2.2% |
| Gross margin | 25.8% |
| ROIC | (6.6%) |
| Total Debt to Equity | 145.8% |
Investment Thesis
High Tide Inc. (HITI) features $199.9M market cap, Quality rating 5.6, intrinsic value $1.4, revenue CA$594.0M (growth 13.7%), FCF CA$13.3M (margin 2.2%), gross margin 25.8%, ROIC -6.6%, debt 145.8%, 1Y Return -12.2%. Retail focus in cannatech.
Key Catalysts
- Strong revenue growth 13.7%.
- Positive FCF CA$13.3M.
- Retail expansion.
Risk Factors
- High debt 145.8%.
- Negative ROIC.
- Modest margins.
Stock #10: Ispire Technology Inc. (ISPR)
| Metric | Value |
|---|---|
| Market Cap | $199.0M |
| Quality Rating | 5.5 |
| Intrinsic Value | $612.0 |
| 1Y Return | -23.1% |
| Revenue | $56.6B |
| Free Cash Flow | ($13.6B) |
| Revenue Growth | (30.3%) |
| FCF margin | (24.0%) |
| Gross margin | 17.5% |
| ROIC | (43.9%) |
| Total Debt to Equity | (108.6%) |
Investment Thesis
Ispire Technology Inc. (ISPR) has $199.0M market cap, Quality rating 5.5, standout intrinsic value $612.0, massive revenue $56.6B despite growth -30.3%, FCF -$13.6B (margin -24.0%), gross margin 17.5%, ROIC -43.9%, debt 108.6%, 1Y Return -23.1%. Scale draws attention for ISPR analysis.
Key Catalysts
- Exceptional intrinsic value $612.0.
- Huge revenue base $56.6B.
- Tech innovation potential.
Risk Factors
- Severe FCF losses and negative growth.
- Negative debt and ROIC.
- Volatility.
Portfolio Diversification Insights
These cannatech stock picks diversify across large-cap stability (MO, STZ at $112.2B and $28.7B) and small-cap growth (CRON, TLRY, etc., under $1B), with ~20% in tobacco/beverages, 60% pure cannabis, 20% tech/industrial. High-quality leaders like MO (ROIC 75.4%) balance negative ROIC plays like TLRY -493.2%, reducing sector-specific risks while capturing upside from revenue growers (CRON 49.0%, HITI 13.7%). Sector allocation favors undervalued opportunities, enhancing portfolio resilience.
Market Timing & Entry Strategies
Consider entry during regulatory clarity or Q4 earnings for growers like CRON/TLRY, using dollar-cost averaging for volatile small-caps. Monitor FCF trends—positive shifts in SNDL/HITI signal strength. Pair with ValueSense tools for intrinsic value tracking; scale into MO/STZ on dips below $62-101 thresholds for conservative positioning in top stocks to buy now.
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2025)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!
More Articles You Might Like
- Yacktman Asset Management Portfolio in 2026: Top Holdings & Recent Changes
- Jensen Investment Management Portfolio in 2026: Top Holdings & Recent Changes
- Abrams Capital Management Portfolio in 2026: Top Holdings & Recent Changes
- Auxier Asset Management Portfolio in 2026: Top Holdings & Recent Changes
- Chase Coleman - Tiger Global Management Portfolio in 2026: Top Holdings & Recent Changes
FAQ Section
How were these stocks selected?
Selected via ValueSense intrinsic value tools, emphasizing quality ratings >4.0, undervaluation gaps, and cannatech relevance for balanced stock watchlist coverage.
What's the best stock from this list?
MO leads with top Quality rating 7.2, ROIC 75.4%, and FCF $11.5B, though TLRY's 689% 1Y return suits aggressive analysis.
Should I buy all these stocks or diversify?
Diversify across large/small caps here—anchor with MO/STZ, allocate 20-30% to high-growth like CRON/TLRY for optimal investment opportunities.
What are the biggest risks with these picks?
Key risks include negative FCF/ROIC in small-caps (e.g., TLRY -493.2%), high debt (MO -1,444.1%), and regulatory shifts in cannatech.
When is the best time to invest in these stocks?
Time entries on positive revenue catalysts or undervaluation dips per ValueSense metrics, using screeners for best value stocks timing.